Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,536 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,903 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04284761 | A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer(Biolen-PC) | completed | Phase 1 | 17 | Alessa Therapeutics Inc.INDUSTRY | 3 | Jun 24, 2024 | clinicaltrials |
| NCT00341939 | Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data | completed | — | 484 | National Cancer Institute (NCI)NIH | 1 |
| Jun 13, 2024 |
| clinicaltrials |
| NCT03276572 | Phase I Trial of 225Ac-J591 in Patients With mCRPC | completed | Phase 1 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT03927391 | Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects(REDOSE) | completed | Phase 4 | 57 | Radboud University Medical CenterOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT03275857 | Cisplatin in Castration Resistant Prostate Cancer | completed | Early Phase 1 | 12 | University of RochesterOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT05324098 | Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy | completed | N/A | 47 | University of California, San FranciscoOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT04986280 | Diagnostic Accuracy and Performance of 18F-PSMA-1007 | completed | — | 174 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT01194271 | Neoadjuvant Ipilimumab in Prostate Cancer | completed | Phase 2 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT05141760 | 18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients | completed | Phase 2 | 150 | University of AlbertaOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT03943368 | Using Virtual Reality (VR) Models for Robotic Prostatectomy | completed | N/A | 92 | Ceevra, Inc.INDUSTRY | 1 | Jun 4, 2024 | clinicaltrials |
| NCT00002981 | PET Scan in Treating Patients With Metastatic Prostate Cancer | completed | N/A | 173 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT02933255 | PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | May 31, 2024 | clinicaltrials |
| NCT02453009 | Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer(CHEIRON) | completed | Phase 2 | 246 | Santa Chiara HospitalOTHER | 1 | May 30, 2024 | clinicaltrials |
| NCT05679193 | Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence(PeP-RALP) | completed | Phase 2 | 40 | Oslo University HospitalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06166758 | Feasibility Study: Educational Genetic Test Video | completed | N/A | 14 | Virginia Commonwealth UniversityOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT02184533 | Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 15 | Stanford UniversityOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT02113657 | T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer | completed | Early Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03629756 | A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies | completed | Phase 1 | 48 | Arcus Biosciences, Inc.INDUSTRY | 2 | May 24, 2024 | clinicaltrials |
| NCT02830165 | Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery | completed | N/A | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT03726320 | Trial of Community Health Worker-led Decision Coaching | completed | N/A | 162 | NYU Langone HealthOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT04604158 | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | completed | N/A | 38 | Gillian GreshamOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT02573584 | Vascular Fingerprint Validation Study | completed | — | 101 | University Medical Center GroningenOTHER | 3 | May 17, 2024 | clinicaltrials |
| NCT05582759 | Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation Therapy(SHERE-Relief 2) | completed | N/A | 45 | University of Kansas Medical CenterOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT05527483 | Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients | completed | — | 32 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05880446 | PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)(PROCAR-BQ) | completed | N/A | 41 | Jules Bordet InstituteOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06206993 | Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical Prostatectomy(RECON) | completed | N/A | 99 | University Hospital HeidelbergOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT02163317 | Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer | completed | N/A | 12 | Case Comprehensive Cancer CenterOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03927521 | Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study(PSMA) | completed | N/A | 11 | Hospices Civils de LyonOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05127850 | MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer | completed | N/A | 51 | University of California, San FranciscoOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT04676334 | CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib(CATCH-R) | completed | Phase 3 | 34 | pharmaand GmbHINDUSTRY | 6 | May 7, 2024 | clinicaltrials |
| NCT02602041 | Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study | completed | — | 38 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT00161174 | Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity | completed | — | 173 | University Medical Center GroningenOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03177460 | Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer | completed | Phase 1 | 33 | M.D. Anderson Cancer CenterOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03358563 | Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer | completed | Early Phase 1 | 30 | University of Wisconsin, MadisonOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT00977860 | Hypofractionated SBRT For Prostate Cancer | completed | N/A | 163 | Adam OlsonOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT04726033 | 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)(CUPID) | completed | Early Phase 1 | 14 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | May 1, 2024 | clinicaltrials |
| NCT03572387 | A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment | completed | Phase 2 | 14 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT04086966 | PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study | completed | Phase 1 | 10 | University of Alabama at BirminghamOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04742959 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 203 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Apr 26, 2024 | clinicaltrials |
| NCT05886751 | Randomized Trial of Trust in Online Videos About Prostate Cancer | completed | N/A | 3,649 | NYU Langone HealthOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06075498 | Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block | completed | N/A | 66 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06380062 | Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia | completed | — | 350 | Universität des SaarlandesOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06372704 | Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence?(HIFEM for PPI) | completed | — | 27 | Kirsehir Ahi Evran UniversitesiOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT01641172 | Taste, Smell and Chemotherapy (TASTY)(TASTY) | completed | Phase 4 | 140 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT05376202 | Image Guided Penile Cancer Surgery(GLANS) | completed | Phase 1 | 11 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | completed | — | 17,667 | Sanguine BiosciencesINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04028388 | ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer | completed | Phase 2 | 135 | Modra PharmaceuticalsINDUSTRY | 6 | Apr 17, 2024 | clinicaltrials |
| NCT05518201 | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old | completed | Phase 1 | 90 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT04089553 | An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer | completed | Phase 2 | 59 | AstraZenecaINDUSTRY | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04260737 | Interactive Decision Aid for Men Diagnosed With Prostate Cancer | completed | N/A | 163 | Reykjavik UniversityOTHER | 1 | Apr 16, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Jun 24, 2024source: clinicaltrials